Table 2. Clinical presentation and histopathologic type (N=84).
Description | Frequency and Proportion n (%) |
Benign neoplasm of nasopharynx | n=33 (40%) |
Malignant neoplasm of nasopharynx | n=37 (45%) |
Malignant neoplasm, unspecified | n=11 (13%) |
Nasopharyngeal myiasis | n=1 (1.2%) |
Initial presenting complains | Frequency and Proportion n (%) |
Nasal obstruction | n=28 (33.3%) |
Nasopharyngeal swelling | n=9 (10.7%) |
Nasal discharge | n=7 (8.3%) |
Hearing loss | n=20 (23.8%) |
Itchiness, cough, long-term snoring | n=5 (6.0%) |
Neck mass | n=11 (13.1%) |
Tinnitus, ear pain | n=4 (4.8%) |
Ear blockage | n=7 (8.3%) |
Histopathologic type | Frequency and Proportion n (%) |
Nonkeratinizing squamous cell carcinoma | n=13 (15.5%) |
Moderately differentiated invasive non-keratinizing carcinoma | n=22 (26.2%) |
Poorly differentiated malignant neoplasm | n=47 (56%) |
Mixed keratinizing and non-keratinizing carcinoma | n=2 (2.4%) |